FT. MYERS, Fla., May 5 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. announced today that it plans to release its first quarter 2008 financial results on Wednesday, May 7, 2008.
About NeoGenomics, Inc.
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.org.
Interested parties can also access additional investor relations material from the American Microcap Institute at http://www.americanmicrocapinstitute.com/ngnm/ or from Hawk Associates at http://www.hawkassociates.com. An investment profile about NeoGenomics may be found at http://www.hawkassociates.com/ngnmprofile.aspx .
Forward Looking Statements
Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements. These forward looking statements involve a number of risks and uncertainties that could cause actual future results to differ materially from those anticipated in the forward looking statements, Actual results could differ materially from such statements expressed or implied herein. Factors that might cause such a difference include, among others, the company's ability to continue gaining new customers, offer new types of tests, and otherwise implement its business plan. As a result, this press release should be read in conjunction with the company's periodic filings with the SEC.
CONTACT: Steven C. Jones, Director of Investor Relations, NeoGenomics,
Inc., +1-239-325-2001, sjones@neogenomics.org; or Frank N. Hawkins or Julie
Marshall, Hawk and Associates, Inc., +1-305-451-1888,
info@hawkassociates.com, for NeoGenomics
Web site: http://www.neogenomics.org/
http://www.hawkassociates.com/ngnmmore.aspx/
http://www.vcall.com/IC/CEPage.asp?ID=129616/
http://www.americanmicrocapinstitute.com/ngnm//
http://www.hawkassociates.com/
http://www.hawkassociates.com/ngnmprofile.aspx/
